logo

Revance Therapeutics Inc (RVNC) Stock: A Year of Declines and Increases

DOYU

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Revance Therapeutics Inc’s current trading price is -57.21% away from its 52-week high, while its distance from the 52-week low is 81.30%. The stock’s price range for this time frame has been between $2.30 and $9.74. The trading volume of the company’s shares in the Healthcare reached around 1.98 million for the day, which was evidently lower than the average daily volume of 3.04 million over the last three months.

The stock market performance of Revance Therapeutics Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $9.74 on 01/02/24, while the lowest price during the same time frame was $2.30, recorded on 06/26/24.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

How Financial Performance Impacts Market Capitalization

Revance Therapeutics Inc (RVNC) has experienced a quarterly decline of -36.53% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 437.45M and boasts a workforce of 597 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 5.10, with a change in price of +0.36. Similarly, Revance Therapeutics Inc recorded 3,833,464 in trading volume during the last 100 days, posting a change of +9.45%.

RVNC Stock Stochastic Average

The raw stochastic average for Revance Therapeutics Inc over the last 50 days is presently at 29.67%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 31.03%. Further, the company’s Stochastic %K and %D values for the last 20 days were 22.22% and 16.86%, respectively.

RVNC Stock Price Performance Analysis

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Year to date metric has recorded a loss of -52.56%.However, over the last six months, we can see a weaker performance of 37.62%. Over the last 30 days, the price of RVNC has leaped by -28.23%. And in the last five days, it has surged by 3.73%.

Most Popular